Related posts

Novo’s Awiqli® receives FDA approval as the first and only once-weekly insulin for children 10 years of age and older with type 2 diabetes

Insulin resistance: Newly identified protein may play key role

FDA Approves Onswik: A Once-Weekly Insulin For Adults With Type 2 Diabetes